A Breast Support Intervention for Women With Breast Pain
A Randomised Control Trial of an Individual Bra Prescription Versus Standard Care for Women With Larger Breasts and Breast Pain
1 other identifier
interventional
33
1 country
2
Brief Summary
The purpose of this study is to assess whether prescribing a bra to participants results in an improvement in the Patient Global Impression of Change (PGIC) compared to participants who receive standard care alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2015
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2015
CompletedFirst Posted
Study publicly available on registry
August 4, 2015
CompletedStudy Start
First participant enrolled
October 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedResults Posted
Study results publicly available
August 7, 2019
CompletedSeptember 9, 2019
August 1, 2019
8 months
July 27, 2015
February 6, 2019
August 26, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Patient Global Impression of Change (PGIC)
Participants will complete the PGIC as part of a questionnaire four weeks after receiving their treatment for benign breast pain 1. = Very much improved (better outcome) 2. = Much improved 3. = Minimally improved 4. = No change 5. = Minimally worse 6. = Much worse 7. = Very much worse (worse outcome)
four weeks post intervention
Patient Global Impression of Change (PGIC)
Participants will complete the PGIC as part of a questionnaire eight weeks after receiving their treatment for benign breast pain
eight weeks post intervention
Study Arms (2)
Prescription group
EXPERIMENTALParticipants in this group will receive the standard care for benign breast pain sufferers (administered by the Queen Alexandra Hospital in Portsmouth) and will also attend the Department of Sport and Exercise Science at the University of Portsmouth for an individual bra prescription. Participants will be prescribed an appropriate bra to wear over an eight week intervention period.
Standard care group
OTHERParticipants in this group will receive the standard care for benign breast pain sufferers administered by the Queen Alexandra Hospital in Portsmouth.
Interventions
Eligibility Criteria
You may qualify if:
- Female, aged 18 years of age and above.
- Experiencing breast pain of any severity.
- Participants must be able to speak and read English fluently
- Participants must be a resident within the local area and not planning to move out of the area within the study timeline
- Participant must have attended the Queen Alexandra (QA) hospital for an assessment of their breast pain.
- Participant is willing and able to give informed consent for participation in the study.
- Participant is self-reported to be between a 34 and 40 under band size and a DD to G bra cup size.
- Able to walk on a treadmill for up to two minutes unaided and be able to walk unaided up and down a small set of steps (assessed verbally by the clinicians at QA hospital)
- Participants must be able to comply with the study procedures
You may not qualify if:
- Participants are receiving any additional treatment for their breast pain that is not part of standard care (recommendation for a bra fit, topical ibuprofen, breast pain leaflet) including any cancer treatment
- Participants have had any surgery to the breasts within the last year
- Participants are currently pregnant or have been pregnant or breast fed in the past year
- Planning to undertake any activities or lifestyle changes which may affect their levels of breast pain e.g. trying for a baby, changing oral contraceptive, having breast surgery.
- Participant's data will be excluded from the analysis if they do not complete either survey at four or eight weeks (at least one follow up survey needs to be completed).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Portsmouthlead
- Portsmouth Hospitals NHS Trustcollaborator
Study Sites (2)
Department of Sport and Exercise Science, University of Portsmouth
Portsmouth, PO1 2ER, United Kingdom
Breast Care Services, Queen Alexandra Hospital
Portsmouth, PO6 3LY, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr Emma Sharland
- Organization
- University of Portsmouth
Study Officials
- PRINCIPAL INVESTIGATOR
Emma Burnett, MRes
University of Portsmouth
- STUDY CHAIR
Joanna Scurr, PhD
University of Portsmouth
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Research Student
Study Record Dates
First Submitted
July 27, 2015
First Posted
August 4, 2015
Study Start
October 1, 2015
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
September 9, 2019
Results First Posted
August 7, 2019
Record last verified: 2019-08